FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.3  |  FHIR Version n/a  User: [n/a]

108594006: Epoprostenol sodium (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
173128019 Epoprostenol sodium en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
602513018 Epoprostenol sodium (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2605931000005115 Epoprostenolnatrium da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Epoprostenol sodium Is a Product containing epoprostenol (medicinal product) false Inferred relationship Some
Epoprostenol sodium Is a Epoprostenol (substance) false Inferred relationship Some
Epoprostenol sodium Is a Prostacyclin PGI2 (substance) true Inferred relationship Some
Epoprostenol sodium This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Epoprostenol (substance) true Inferred relationship Some
Epoprostenol sodium This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Platelet aggregation inhibitor (disposition) true Inferred relationship Some
Epoprostenol sodium Is a Platelet aggregation inhibitor true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Epoprostenol sodium 0.5mg/vial powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Epoprostenol sodium Inferred relationship Some
Epoprostenol sodium 1.5mg/vial powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Epoprostenol sodium Inferred relationship Some
epoprostenol 1,5 mg pulver og solvent til infusionsvæske, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Epoprostenol sodium Inferred relationship Some
epoprostenol 500 µg pulver og solvent til infusionsvæske, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Epoprostenol sodium Inferred relationship Some
Epoprostenol (as epoprostenol sodium) 1.5 mg powder for solution for injection vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Epoprostenol sodium Inferred relationship Some 1
Product containing precisely epoprostenol (as epoprostenol sodium) 500 microgram/1 vial powder for conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Epoprostenol sodium Inferred relationship Some 1
Epoprostenol (as epoprostenol sodium) 1.5 mg powder for solution for infusion vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Epoprostenol sodium Inferred relationship Some 1
Product containing precisely epoprostenol (as epoprostenol sodium) 500 microgram/1 vial powder for conventional release solution for infusion (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Epoprostenol sodium Inferred relationship Some 1
Epoprostenol (as epoprostenol sodium) 1.5 mg powder for solution for infusion and/or injection vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Epoprostenol sodium Inferred relationship Some 1
Product containing precisely epoprostenol (as epoprostenol sodium) 500 microgram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Epoprostenol sodium Inferred relationship Some 1

This concept is not in any reference sets

Back to Start